Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-04-14 | 2023-07-07 | 189653 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2017-09-27 | 2017-10-02 | 23663 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2018-03-05 | 2018-03-20 | 41868 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-04-04 | 2019-05-21 | 80530 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-07-12 | 2019-08-17 | 89158 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2019-09-04 | 2019-09-06 | 92974 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2021-04-09 | 2021-06-07 | 137241 |
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 300MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-05-23 | 14 |
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 300MG 150MG | TABLET | Resolved | 2018-12-05 | 2022-12-13 | 68700 |
APO-ABACAVIR | 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-28 | 8 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-03-10 | 2017-10-30 | 122 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-03-10 | 2018-12-18 | 287 |
APO-IRBESARTAN | 300MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 339 |
APO-PROPAFENONE | 300MG | TABLET | Resolved | 2017-03-11 | 2018-08-30 | 460 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-03-11 | 2017-07-13 | 661 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Resolved | 2017-05-04 | 2017-07-22 | 8889 |
APO-PREGABALIN | 300MG | CAPSULE | Resolved | 2017-05-24 | 2017-09-22 | 11041 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-06-06 | 2017-08-16 | 12064 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Resolved | 2017-06-08 | 2017-07-26 | 12364 |
APO-LAMIVUDINE | 300MG | TABLET | Resolved | 2017-07-11 | 2017-08-31 | 15271 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |